Li-qi, Q., Xiao-hua, P., Rong-ming, C. et al. Effect of Lirukang oral liquid on neurotransmitters and estrogen in rats with hyperplasia of mammary gland., Chin. J. Integr. Med. 10, 131–134 (2004). https://doi.org/10.1007/BF02836386
Qian Li-qi, Pei Xiao-hua, Chen Rong-ming, et al. Effect of Lirukang oral liquid on neurotransmitters and estrogen in rats with hyperplasia of mammary gland. [J]. Chinese Journal of Integrative Medicine 10(2):131-134(2004)
Li-qi, Q., Xiao-hua, P., Rong-ming, C. et al. Effect of Lirukang oral liquid on neurotransmitters and estrogen in rats with hyperplasia of mammary gland., Chin. J. Integr. Med. 10, 131–134 (2004). https://doi.org/10.1007/BF02836386DOI:
Qian Li-qi, Pei Xiao-hua, Chen Rong-ming, et al. Effect of Lirukang oral liquid on neurotransmitters and estrogen in rats with hyperplasia of mammary gland. [J]. Chinese Journal of Integrative Medicine 10(2):131-134(2004) DOI: 10.1007/BF02836386.
Effect of Lirukang oral liquid on neurotransmitters and estrogen in rats with hyperplasia of mammary gland
摘要
Objective: To investigate the effects of Lirukang oral liquid (LRK) on release of neurotransmitter in rats with hyperplasia of mammary glands (HMG) and to explore its mechanism.Methods: Sixty rats were divided into six groups
the normal control group
the model control group
the large dosage (3.6g/kg) and the small dosage (1.8g/kg) LRK groups
the Ruzengning (RZN
2.5g/kg) group and the tamoxifen (TAM
5mg/kg) group
10 in each group. Except those in the normal control group
all the animals were made into rat model of HMG by intraperitoneal injection of estradiol benzoate. Levels of dopamine (DA) and 5-hydroxytryptamine (5-HT) in hypothalamus and mammary gland in rats were detected by fluorescence luminosity assay
and level of prolactin (PRL) in serum was detected by radioimmunoassay.Results: In the model group
the level of DA reduced significantly (P<0.01)
and 5-HT and PRL increased obviously (P<0.01). Compared with the model group
the LRK groups of both dosages and the TAM group had their level of DA significantly increased (P<0.01)
and level of 5-HT significantly decreased (P<0.01). The serum PRL in both LRK groups was significantly decreased (P<0.01). No obvious changes in DA
5-HT and PRL were found in the RZN group.Conclusion: LRK and TAM have similar effects in regulating the release of neurotransmitter in hypothalamus and mammary gland and serum content of estrogen in the animal models of HMG.
Abstract
Objective: To investigate the effects of Lirukang oral liquid (LRK) on release of neurotransmitter in rats with hyperplasia of mammary glands (HMG) and to explore its mechanism.Methods: Sixty rats were divided into six groups
the normal control group
the model control group
the large dosage (3.6g/kg) and the small dosage (1.8g/kg) LRK groups
the Ruzengning (RZN
2.5g/kg) group and the tamoxifen (TAM
5mg/kg) group
10 in each group. Except those in the normal control group
all the animals were made into rat model of HMG by intraperitoneal injection of estradiol benzoate. Levels of dopamine (DA) and 5-hydroxytryptamine (5-HT) in hypothalamus and mammary gland in rats were detected by fluorescence luminosity assay
and level of prolactin (PRL) in serum was detected by radioimmunoassay.Results: In the model group
the level of DA reduced significantly (P<0.01)
and 5-HT and PRL increased obviously (P<0.01). Compared with the model group
the LRK groups of both dosages and the TAM group had their level of DA significantly increased (P<0.01)
and level of 5-HT significantly decreased (P<0.01). The serum PRL in both LRK groups was significantly decreased (P<0.01). No obvious changes in DA
5-HT and PRL were found in the RZN group.Conclusion: LRK and TAM have similar effects in regulating the release of neurotransmitter in hypothalamus and mammary gland and serum content of estrogen in the animal models of HMG.
关键词
Lirukang oral liquidhyperplasia of mammary glandsneurotransmitterrats
Keywords
Lirukang oral liquidhyperplasia of mammary glandsneurotransmitterrats
references
Duan YL, Zhang XM, Shen ZY, et al. Effect of three kinds of Chinese composite recipes (supplementing Shen, strengthening Pi and activating blood circulation) on content of monoamine transmitters in hypothalamus of rats Induced by intracerebroventricular injection of interleukin-1. Chin J Integr Tradit West Med 1999; 19 (3): 164–166.
Rao JC, Li LZ, Chen YS, et al. Duplication of animal model with hyperplasia of mammary glands and their pathological types. Chin J Pathophysiol 1992; 8(6): 671–672.
Zhu Y, Duo XY. Experimental animal models of diseases. Tianjin: Tianjin Technological Translation Publishing Company, 1997: 392
Maslar IA, Kaplan BM, Luciano AA, et al. Prolactin production by the endomertium of early human pregnancy. J Clin Endocrinol Metab 1980; 51: 70–75.
Zheng YC. Animal hormones and their application. Nanjing: Jiangsu Science & Technology Publishing House, 1996: 50.
Yu AF. Gynecologic and obstetric endocrinology (the last volume). Shanghai: Shanghai Science and Technology Publishing House, 1985: 30–33.
Zhou QL, Bao HY, Zhang YW, et al. Study of deerhorn on Treatment Rupi (nodules of breast): II. Study on mechanism of deerhorn extract in inhibiting hyperplasia of mammary glands. Pharmacol Clin Chin Materia Med 1998:14(3): 23–25.
Yang DH, Cai SQ, Wang X, et al. Inhibition of Radix Astragali and Radix polygoni multiflori on induction of thymocyte apoptosis by CTX. J China Pharm University 2000;31(1): 35–38.
Wang Y, Ma AL, Zhang HZ, et al. Experimental study on anticancer effects of oyster shell extracts. Chin J Marine Drugs 1997; 16(1): 18–22.
Wen L, Yuan J. Effects of Lijiang appendiculate cremastra pseudobulb. Chin J Ethomedicine &. Ethopharmacy 2003; 62(3): 180–181.
Yuan SJ, Han R. Chemical preventive effect of curcumin on cancer. Foreign Medical Sciences: Cancer Section 1997;24(5): 2664–268.
Qian LQ, Pei XH, Xu ZY. The effects of Lirukang oral liquid on integral condition of pathological model of hyperplasia of mammary glands. Acta of Nanjing University of TCM 2002; 18(3): 167–168